Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Helius Medical Technologies Inc HSDT

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.


NDAQ:HSDT - Post by User

Comment by prokofievon Nov 14, 2017 11:45pm
286 Views
Post# 26965378

RE:RE:RE:RE:Andreeff buying shares

RE:RE:RE:RE:Andreeff buying sharesI think this is an overly simplistic analysis of the situation. First, the President’s Club newsletter only mentions that “Helius is planning to rebut the report, so it’s probably a good idea to wait for that before acting”. It never says the results will be published a day or two after the TBI trial results were released. If I have mentioned this possibility before, I never meant soon as in “days”, but more “weeks”. To be honest, I have no idea of the timelines, but I am positive something is coming.
 
I have heard some chatter about new rehabilitation clinics opening sometime next year in Canada which could be using the PoNS device with real life patients, recall the FDA approval is for the US market only. I will try to dig out some additional information, as if those clinics are under construction or soon to be, funds must already have been secured and we should be able to find some information online. Please let me know if any one of you finds something related to this, the more we dig the more we uncover.
 
Prokofiev
 

miningfundi wrote: Thanks for the link Prokofiev, very useful. What confused me was that the shares were traded over three days ending Monday, and the price was in US$. The bad news is that if a news release were coming soon, there would be an insider trading blackout.


Bullboard Posts